Caplin Group announces strategic investment of Rs. 700 crore in TN

This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited

Lupin launches second edition of Aptivate Champion Run for Kids

Lupin Life encourages children from Mumbai, Thane, and Navi Mumbai to participate in Aptivate Champion Run

Jiangsu Vcare files NDA for Vicagrel Capsules with USFDA

CCRAS launches ‘SMART 2.0’ for ayurveda teaching professionals

Mandaviya lays foundation stone for NCDC regional branch, state branches and 2 BSL-3 laboratories

Dedicates upgraded National Centre for Disease Control, Delhi and a Temporary Regional Branch of NCDC to the nation

Alembic Pharmaceuticals received 8 USFDA approvals in Q3FY24

The company has received five final approvals

Sun Pharma to acquire 16.7% stake in Lyndra Therapeutics for $30 mn

According to Sun Pharma, the purpose of the strategic investment is to obtain access to the technology for certain compounds and territories while also fostering the development of novel pharmaceutical delivery systems.

Palatin completes sale of Vyleesi to Cosette Pharmaceuticals for up to $171 mn

Vyleesi is the first and only as-needed treatment approved by the Food and Drug Administration (FDA) for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)

Venus Remedies secures marketing approval from Israel, Colombia for two oncology drugs

The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia

Ecolab recognised by DJSI World and North America Indices

Ecolab’s continued leadership position on renowned sustainability indices demonstrates the company’s record of advancing sustainable growth